NIH Scientists Develop Blood Test to Help Improve Liver Cancer Screening
A specific viral exposure signature that could accurately distinguish people with HCC from those with chronic liver disease and healthy volunteers.
Read MorePosted by Laurie Bonner | Jun 12, 2020 | Uncategorized |
A specific viral exposure signature that could accurately distinguish people with HCC from those with chronic liver disease and healthy volunteers.
Read MorePosted by Laurie Bonner | Jun 11, 2020 | Uncategorized |
The kit is intended for the calibration, or calibration verification, of total protein and albumin concentrations in both urine and cerebrospinal fluid.
Read MorePosted by Steve Halasey | Jun 9, 2020 | Covid 19 |
Covid-19 severity score, built with data from China and New York City, can help clinicians identify the most at-risk patients.
Read MorePosted by Laurie Bonner | May 18, 2020 | Uncategorized |
The EKF desktop analyzer will complement Tosoh’s line of high-performance liquid chromatography equipment for HbA1c analysis in core laboratories.
Read MorePosted by | Apr 2, 2020 | POC Instruments, POC Rapid Assays, POC Reagents & Test Kits, Point-of-Care |
The FDA CLIA-waived handheld analyzer reliably and efficiently delivers results within just 5 to 10 seconds, and it can be used in point-of-care (POC) and certificate of waiver settings, such as physicians’ offices, clinics, and other nontraditional laboratory locations.
Read More